Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M456Revenue $M174Net Margin (%)-39.5Altman Z-Score-1.1
Enterprise Value $M277EPS $-1.5Operating Margin %-35.9Piotroski F-Score4
P/E(ttm)--Beneish M-Score1.3Pre-tax Margin (%)-39.4Higher ROA y-yY
Price/Book5.210-y EBITDA Growth Rate %--Quick Ratio3.6Cash flow > EarningsY
Price/Sales2.65-y EBITDA Growth Rate %-24.5Current Ratio3.6Lower Leverage y-yN
Price/Free Cash Flow8.9y-y EBITDA Growth Rate %--ROA % (ttm)-23.9Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-42.9Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M49.2ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with INFI

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
INFIGeorge Soros 2013-06-30 Sold Out -0.02%$16.192 - $50.09
($30.95)
$ 9.28-70%Sold Out0
INFIGeorge Soros 2013-03-31 Reduce-0.01%$32.93 - $49.37
($39.51)
$ 9.28-77%Reduce 46.67%40,000
INFIGeorge Soros 2012-12-31 Buy 0.03%$17.74 - $35.04
($25.26)
$ 9.28-63%New holding75,000
INFIFirst Eagle Investment 2012-06-30 Sold Out -0.01%$11.71 - $13.76
($12.78)
$ 9.28-27%Sold Out0
INFIFirst Eagle Investment 2012-03-31 Reduce-0.01%$5.9781 - $12.16
($7.96)
$ 9.2817%Reduce 54.94%180,000
INFIFirst Eagle Investment 2011-09-30 Reduce-0.01%$6.17 - $10.36
($7.87)
$ 9.2818%Reduce 25.85%464,241
INFIWilbur Ross 2011-06-30 Sold Out $5.61 - $8.19
($6.53)
$ 9.2842%Sold Out0
INFIWilbur Ross 2010-12-31 Reduce-0.02%$5.12 - $6.86
($6.13)
$ 9.2851%Reduce 63.91%7,415
INFIFirst Eagle Investment 2010-12-31 Add0.01%$5.12 - $6.86
($6.13)
$ 9.2851%Add 60.34%585,437
INFIWilbur Ross 2010-09-30 Reduce-0.01%$4.62 - $6.3
($5.51)
$ 9.2868%Reduce 25.39%20,545
INFIFirst Eagle Investment 2010-09-30 Add$4.62 - $6.3
($5.51)
$ 9.2868%Add 29.72%365,123
INFIFirst Eagle Investment 2010-06-30 Add0.01%$5.88 - $7.94
($6.59)
$ 9.2841%Add 566.95%281,460
INFIFirst Eagle Investment 2009-12-31 Add$5.5 - $6.57
($5.92)
$ 9.2857%Add 451.43%42,201
INFIFirst Eagle Investment 2009-09-30 Buy $5.42 - $8.8
($6.97)
$ 9.2833%New holding7,653
INFIWilbur Ross 2009-03-31 Buy 0.12%$7.1 - $8.28
($7.9)
$ 9.2817%New holding28,437
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

INFI is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


INFI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Perkins Adelene QPresident & CEO 2015-06-25Sell5,000$10.93-15.1 view
Palombella Vito J.Chief Scientific Officer 2015-06-15Sell4,737$10.97-15.41 view
Perkins Adelene QPresident & CEO 2015-05-27Sell10,000$12.81-27.56 view
Perkins Adelene QPresident & CEO 2015-05-14Sell10,000$12.18-23.81 view
Perkins Adelene QPresident & CEO 2015-03-16Sell20,000$16-42 view
Perkins Adelene QPresident & CEO 2015-03-05Sell25,000$16.5-43.76 view
Perkins Adelene QPresident & CEO 2015-01-29Sell20,000$14.83-37.42 view
Perkins Adelene QPresident & CEO 2015-01-29Sell20,000$14.83-37.42 view
Palombella Vito J.Chief Scientific Officer 2014-12-15Sell4,737$16.32-43.14 view
Palombella Vito J.Chief Scientific Officer 2014-11-26Sell4,736$15-38.13 view

Quarterly/Annual Reports about INFI:

    News about INFI:

    Articles On GuruFocus.com
    own Mar 02 2015 
    comment on INFI Mar 02 2013 
    INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q/A) Mar 15 2011 
    INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q/A) Mar 15 2011 
    INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q/A) Mar 15 2011 
    INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q) Aug 04 2010 
    INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q) May 06 2010 
    INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q) Aug 06 2009 
    Infinity Pharmaceuticals Inc. Reports Operating Results (10-Q) May 06 2009 

    More From Other Websites
    INFINITY PHARMACEUTICALS, INC. Financials Aug 13 2015
    Infinis Energy plc Q1 trading statement for the period 1 April 2015 to date Aug 13 2015
    Puma Biotechnology's (PBYI) Q2 Loss Wider than Expected Aug 12 2015
    Theravance Biopharma Posts Narrower Q2 Loss, View Revised - Analyst Blog Aug 11 2015
    AVEO Pharmaceuticals Posts Narrower-than-Expected Loss - Analyst Blog Aug 11 2015
    Edited Transcript of INFI earnings conference call or presentation 6-Aug-15 12:30pm GMT Aug 06 2015
    Infinity Provides Company Update and Reports Second Quarter 2015 Financial Results Aug 06 2015
    Infinity reports 2Q loss Aug 06 2015
    Infinity reports 2Q loss Aug 06 2015
    INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Aug 06 2015
    Infinity Provides Company Update and Reports Second Quarter 2015 Financial Results Aug 06 2015
    INFINITY PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report Aug 06 2015
    Q2 2015 Infinity Pharmaceuticals Inc Earnings Release - Before Market Open Aug 06 2015
    Infinity Announces the Date of Its Second Quarter 2015 Financial Results Conference Call and Webcast Jul 30 2015
    Infinity Announces the Date of Its Second Quarter 2015 Financial Results Conference Call and Webcast Jul 30 2015
    Infinity to Participate in Two Upcoming Conferences Jul 21 2015
    Infinity to Participate in Two Upcoming Conferences Jul 21 2015
    INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers,... Jun 16 2015
    Infinity Reports Phase 1 Data Showing Clinical Activity of Duvelisib in Treatment-Naïve Patients... May 31 2015
    Infinity Reports Phase 1 Data Showing Clinical Activity of Duvelisib in Treatment-Naïve Patients... May 31 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK